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Background
To target HIV-1 specific CTL epitopes that are subdomi-
nant in the context of natural infection we designed a pep-
tide based vaccine in order to induce a balanced CD4+
and CD8+ cellular immune response. We believe that
inducing CD4+ T cell responses would provide help and
allow for responses against sub-dominant epitopes to
come forward.
Methods
In a phase I/II therapeutic HIV-1 vaccine trial 12 treatment
naïve HIV-1 infected Danish individuals received 1 × 10e7
autologous monocyte derived dendritic cells s.c. (week 0,
2, 4 and 8) pulsed with 10 different peptides, 7 CTL
epitopes from conserved regions of HIV-1 and two HIV-1
derived and one universal T helper epitope. Novel T cell
responses were evaluated by intracellular cytokine stain-
ing for IFN-γ, TNF-α and IL-2.
Results
This mode of vaccination generated robust polyfunctional
vaccine specific CD4+ T cell responses sustained at the last
evaluation, 6 months after the last immuniza-tion.
Cytokine responses were dominated by TNF-α and IL-2
production, indicative of long-lived central memory cells.
Moreover, in 12 out of 12 patient's vaccine specific CD8+
T cell responses were detected.
Conclusion
This suggests that this mode of vaccination, dendritic cells
loaded with a combination of T helper and CTL epitope
peptides, is a successful approach to target subdominant
epitopes and the possibility to re-direct the immune
response towards selected epitopes during chronic HIV-1
infection is an important proof of concept.
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